Sotera Health, Warburg Pincus, and GTCR in $470 Million Secondary Stock Offering

Cleary Gottlieb represented Sotera Health Company (Sotera Health) and two of its principal shareholders, Warburg Pincus and GTCR, in its $470 million secondary public offering of 30 million shares of common stock.

The offering priced on November 6, 2025, and is expected to close on November 10, 2025. All of the shares of common stock offered are being sold by the selling shareholders. Sotera Health is not selling any shares and will not receive any proceeds from the offering.

Goldman Sachs & Co. LLC is acting as underwriter for the offering.

Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the health care industry.

The Cleary capital markets team included partners David Lopez and Adam Fleisher, senior attorney David Parish, and associate Aditi Thakur, with assistance from law clerk Ville Latola. Partner Matt Brigham advised on U.S. tax matters.